Cancer treatment combining lymphodepleting agent with CTLs and cytokines

Details for Australian Patent Application No. 2007222080 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Peterson, Per A.; Cai, Zeling; Moriarty, Ann; Richards, Jon M.

Agent Shelston IP

Pub. Number AU-B-2007222080

PCT Pub. Number WO2007/103009

Priority 60/778,516 01.03.06 US

Filing date 23 February 2007

Wipo publication date 13 September 2007

Acceptance publication date 16 August 2012

International Classifications

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A01N 63/00 Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A61K 38/21 Medicinal preparations containing peptides - Interferons

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103009 Priority application(s): WO2007/103009

16 August 2012 Application Accepted

  Published as AU-B-2007222080

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222081-Online systems, methods, and interfaces for providing pharmaceutical information

2007222072-Label applicator system